` Comparison: KREBSBIO, LLY - Alpha Spread

K
KREBSBIO
vs
LLY

Over the past 12 months, KREBSBIO has underperformed LLY, delivering a return of -25% compared to the LLY's +41% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
KREBSBIO
LLY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

K
KREBSBIO Intrinsic Value
72.32 INR
Undervaluation 2%
Intrinsic Value
Price
LLY Intrinsic Value
418.15 USD
Overvaluation 61%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
K
Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO
70.97 INR
Eli Lilly and Co
NYSE:LLY
1 080.36 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
KREBSBIO, LLY

KREBSBIO
LLY
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
K
Krebs Biochemicals and Industries Ltd
Revenue
Eli Lilly and Co
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
KREBSBIO, LLY

KREBSBIO
LLY
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
K
Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO
Eli Lilly and Co
NYSE:LLY
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

KREBSBIO
92%
LLY
83%

Operating Margin

KREBSBIO
-79%
LLY
44.4%

Net Margin

KREBSBIO
-101%
LLY
31%

FCF Margin

KREBSBIO
-28.3%
LLY
10.8%

ROE

KREBSBIO
19.1%
LLY
96.8%

ROA

KREBSBIO
-15.6%
LLY
19.3%

ROIC

KREBSBIO
-14%
LLY
25.4%

ROCE

KREBSBIO
-31.2%
LLY
42%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
KREBSBIO, LLY

Loading
KREBSBIO
LLY
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
KREBSBIO, LLY

Loading
KREBSBIO
LLY
Difference
www.alphaspread.com

Performance By Year
KREBSBIO, LLY

Loading
KREBSBIO
LLY
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare KREBSBIO to other stocks
Unlock Full Access to Alpha Spread
Create Free Account